Related references
Note: Only part of the references are listed.Human papillomavirus vaccine against cervical cancer: Opportunity and challenge
Renjie Wang et al.
CANCER LETTERS (2020)
Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis
Marc Arbyn et al.
LANCET GLOBAL HEALTH (2020)
Combination therapy using human papillomavirus L1/E6/E7 genes and archaeosome: a nanovaccine confer immuneadjuvanting effects to fight cervical cancer
Hesam Karimi et al.
SCIENTIFIC REPORTS (2020)
Factors Which Contribute to the Immunogenicity of Non-replicating Adenoviral Vectored Vaccines
Lynda Coughlan
FRONTIERS IN IMMUNOLOGY (2020)
A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer
Qianqian Ni et al.
SCIENCE ADVANCES (2020)
Tumor cell membrane enveloped aluminum phosphate nanoparticles for enhanced cancer vaccination
Jingyao Gan et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Heterologous prime-boost immunization co-targeting dual antigens inhibit tumor growth and relapse
Qianqian Guo et al.
ONCOIMMUNOLOGY (2020)
Co-assembled and self-delivered epitope/CpG nanocomplex vaccine augments peptide immunogenicity for cancer immunotherapy
Xiaoguang Shi et al.
CHEMICAL ENGINEERING JOURNAL (2020)
Heterologous prime-boost vaccination protects against EBV antigen-expressing lymphomas
Julia Ruhl et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Vaccine adjuvants: Understanding the structure and mechanism of adjuvanticity
Shuting Shi et al.
VACCINE (2019)
Vaccination with synthetic long peptide formulated with CpG in an oil-in-water emulsion induces robust E7-specific CD8 T cell responses and TC-1 tumor eradication
Sean K. Maynard et al.
BMC CANCER (2019)
Prophylactic vaccination against human papillomaviruses to prevent vulval and vaginal cancer and their precursors
Lan Xu et al.
EXPERT REVIEW OF VACCINES (2019)
Reprogramming the adjuvant properties of aluminum oxyhydroxide with nanoparticle technology
Mark T. Orr et al.
NPJ VACCINES (2019)
Turning the Old Adjuvant from Gel to Nanoparticles to Amplify CD8(+) T Cell Responses
Hao Jiang et al.
ADVANCED SCIENCE (2018)
The vaccine adjuvant alum promotes IL-10 production that suppresses Th1 responses
Ewa Oleszycka et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2018)
Heterologous prime-boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus
Seo-Yeon Jung et al.
VACCINE (2018)
CpG incorporated DNA microparticles for elevated immune stimulation for antigen presenting cells
Heejung Jung et al.
RSC ADVANCES (2018)
Synergy effects of Polyinosinic-polycytidylic acid, CpG oligodeoxynucleotide, and cationic peptides to adjuvant HPV E7 epitope vaccine through preventive and therapeutic immunization in a TC-1 grafted mouse model
Cunbao Liu et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems
M. Danaei et al.
PHARMACEUTICS (2018)
Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want
Harm HogenEsch et al.
NPJ VACCINES (2018)
Therapeutic vaccines for high-risk HPV-associated diseases
Aleyo Chabeda et al.
PAPILLOMAVIRUS RESEARCH (2018)
Efficacy of L1 Protein Vaccines Against Cervical and Vaginal Cancer: A Systematic Review and Meta-Analysis
Tahoora Mousavi et al.
IRANIAN RED CRESCENT MEDICAL JOURNAL (2017)
CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies
Nobutaka Hanagata
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
A STING-activating nanovaccine for cancer immunotherapy
Min Luo et al.
NATURE NANOTECHNOLOGY (2017)
Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma
Cristian Capasso et al.
ONCOIMMUNOLOGY (2016)
Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment
Allan Hildesheim et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2016)
Oncolytic Adenovirus Loaded with L-carnosine as Novel Strategy to Enhance the Antitumor Activity
Mariangela Garofalo et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Surface charge critically affects tumor penetration and therapeutic efficacy of cancer nanomedicines
Hong-Xia Wang et al.
NANO TODAY (2016)
Enhancement of fibroblast activation protein α-based vaccines and adenovirus boost immunity by cyclophosphamide through inhibiting IL-10 expression in 4T1 tumor bearing mice
Qiu Xia et al.
VACCINE (2016)
Nanomaterial-based vaccine adjuvants
Bingbing Sun et al.
JOURNAL OF MATERIALS CHEMISTRY B (2016)
Adjuvants for peptide-based cancer vaccines
Hiep Khong et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Advances in aluminum hydroxide-based adjuvant research and its mechanism
Peng He et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Nanoparticle-Based Immunotherapy for Cancer
Kun Shao et al.
ACS NANO (2015)
Aluminum hydroxide nanoparticles show a stronger vaccine adjuvant activity than traditional aluminum hydroxide microparticles
Xinran Li et al.
JOURNAL OF CONTROLLED RELEASE (2014)
A Heterologous Prime/Boost Vaccination Strategy Enhances the Immunogenicity of Therapeutic Vaccines for Hepatitis C Virus
Anne Fournillier et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Host DNA released in response to aluminum adjuvant enhances MHC class II-mediated antigen presentation and prolongs CD4 T-cell interactions with dendritic cells
Amy S. McKee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Kinetics of the inflammatory response following intramuscular injection of aluminum adjuvant
Fangjia Lu et al.
VACCINE (2013)
Alum increases antigen uptake, reduces antigen degradation and sustains antigen presentation by DCs in vitro
Tirth R. Ghimire et al.
IMMUNOLOGY LETTERS (2012)
Silica Crystals and Aluminum Salts Regulate the Production of Prostaglandin in Macrophages via NALP3 Inflammasome-Independent Mechanisms
Etsushi Kuroda et al.
IMMUNITY (2011)
Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity
Tracy L. Flach et al.
NATURE MEDICINE (2011)
Three CpG oligodeoxynucleotide classes differentially enhance antigen-specific humoral and cellular immune responses in mice
Ying Liu et al.
VACCINE (2011)
Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes
Samuele Calabro et al.
VACCINE (2011)
Updated aluminum pharmacokinetics following infant exposures through diet and vaccination
Robert J. Mitkus et al.
VACCINE (2011)
Trivalent Adenovirus Type 5 HIV Recombinant Vaccine Primes for Modest Cytotoxic Capacity That Is Greatest in Humans with Protective HLA Class I Alleles
Stephen A. Migueles et al.
PLOS PATHOGENS (2011)
Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods
Yang Qiu et al.
BIOMATERIALS (2010)
Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles
Chunbai He et al.
BIOMATERIALS (2010)
IL-10 production differentially influences the magnitude, quality, and protective capacity of Th1 responses depending on the vaccine platform
Patricia A. Darrah et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists
Joerg Vollmer et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Effect of surface charge and agglomerate degree of magnetic iron oxide nanoparticles on KB cellular uptake in vitro
Yuqing Ge et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2009)
Strategies to overcome host immunity to adenovirus vectors in vaccine development
Erin E. Thacker et al.
EXPERT REVIEW OF VACCINES (2009)
Perforin and Gamma Interferon Expression Are Required for CD4+ and CD8+ T-Cell-Dependent Protective Immunity against a Human Parasite, Trypanosoma cruzi, Elicited by Heterologous Plasmid DNA Prime-Recombinant Adenovirus 5 Boost Vaccination
Bruna C. G. de Alencar et al.
INFECTION AND IMMUNITY (2009)
Physiologic upper limit of pore size in the blood-tumor barrier of malignant solid tumors
Hemant Sarin et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
Adenovirus Virion Stability and the Viral Genome: Size Matters
Michael A. Kennedy et al.
MOLECULAR THERAPY (2009)
Understanding the Role of Surface Charges in Cellular Adsorption versus Internalization by Selectively Removing Gold Nanoparticles on the Cell Surface with a I2/KI Etchant
Eun Chul Cho et al.
NANO LETTERS (2009)
Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection - A randomized trial
Allan Hildesheim et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Effect of alternative aluminum adjuvants on the absorption and immunogenicity of HPV16 L1 VLPs in mice
Michael J. Coulfield et al.
HUMAN VACCINES (2007)
Activation of dendritic cells and induction of CD4+ T cell differentiation by aluminum-containing adjuvants
Anna Sokolovska et al.
VACCINE (2007)
Generation of anti-tumor immunity using mammalian heat shock protein 70 DNA vaccines for cancer immunotherapy
Ying Li et al.
VACCINE (2006)
Vaccination with human papillomavirus type 16 E7 peptide with CpG oligonucleotides for prevention of tumor growth in mice
KB Gendron et al.
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2006)
Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro
GL Morefield et al.
VACCINE (2005)
C-class CpG ODN: sequence requirements and characterization of immunostimulatory activities on mRNA level
M Jurk et al.
IMMUNOBIOLOGY (2004)
Adenovirus hexon protein is a potent adjuvant for activation of a cellular immune response
V Molinier-Frenkel et al.
JOURNAL OF VIROLOGY (2002)
Pre-clinical safety and efficacy of TA-CIN, a recombinant HPV16 L2E6E7 fusion protein vaccine, in homologous and heterologous prime-boost regimens
SH van der Burg et al.
VACCINE (2001)
CpG-DNA-mediated transient lymphadenopathy is associated with a state of Th1 predisposition to antigen-driven responses
GB Lipford et al.
JOURNAL OF IMMUNOLOGY (2000)
Recombinant adenoviral vectors have adjuvant activity and stimulate T cell responses against tumor cells
SB Geutskens et al.
GENE THERAPY (2000)
Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8+ cytotoxic T lymphocytes
AD Santin et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
